Nanjing Tengchen Biotechnology Co.
Latest round
- Angel
Last raised
- Jun 2018
Total raised
- Undisclosed
Investors
- 2
About Nanjing Tengchen Biotechnology Co.
Established in 2018 and based in Nanjing, China, Tantica is a biological technology company that focuses on development of tumor in diagnostic technology and products. The founder and CEO (Chief Executive Officer) Prof. Rongxi Yang received a PhD in molecular epidemiology from the German National Cancer Research Center in 2011 and has been a professor in the Department of Epidemiology, School of Public Health, Nanjing Medical University. She served as a researcher at the German National Cancer Research Center and Heidelberg University Medical School. The company has 1,600 square meters of R&D center and medical testing laboratory. The company's main provides early cancer diagnosis, prognosis evaluation, curative effect evaluation and recurrence monitoring services for customers. The company's self-developed DNA methylation technology, research and development platform has the function of mark tumor biology, tumor treatment and cut off tumor invasion and metastasis. The company another product matrix-assisted laser desorption ionization time-of-flight mass spectrometry(MALDI-TOF MS)mainly used for clinical microbial identification, genotyping analysis, biomarker identification, pathogen identification and mass spectrometry imaging. The company has two product Feijieming and Feichangan, Feijieming is use to differential diagnosis test for benign and malignant pulmonary nodules and Feichangan is use to early lung cancer screening and testing.
Who invested in Nanjing Tengchen Biotechnology Co.
2 investors across 1 round
See all investors in Nanjing Tengchen Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Jun 14, 2018
Amount
Undisclosed
Investors
Questions about Nanjing Tengchen Biotechnology Co.
Who invested in Nanjing Tengchen Biotechnology Co.?
Nanjing Tengchen Biotechnology Co. has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nanjing Tengchen Biotechnology Co. raised?
Nanjing Tengchen Biotechnology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nanjing Tengchen Biotechnology Co. last raise money?
Nanjing Tengchen Biotechnology Co.'s most recent round on record is a Angel, in Jun 2018.
What does Nanjing Tengchen Biotechnology Co. do?
Established in 2018 and based in Nanjing, China, Tantica is a biological technology company that focuses on development of tumor in diagnostic technology and products.
Where is Nanjing Tengchen Biotechnology Co. headquartered?
Nanjing Tengchen Biotechnology Co. is headquartered in Nanjing, China.
Which VCs invest in companies like Nanjing Tengchen Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Nanjing Tengchen Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Nanjing Tengchen Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.